Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

NCT01256762 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Recurrent or Metastatic Breast Cancer

Interventions

DRUG: Imetelstat sodium
DRUG: Bevacizumab
DRUG: Paclitaxel

Sponsor

Geron Corporation